Early enrolment completion in the global M72 Phase 3 TB vaccine trial marks a significant milestone, with Durban sites ...

Bacille Calmette-Guérin revaccination shows no efficacy in preventing sustained Mycobacterium tuberculosis infection compared with placebo in adolescents in a phase 2b study.

Image=KCDC Amid the increased possibility of using artificial intelligence (AI) for care due to aging, a senior medication ...

The study followed 351 patients across four Korean hospitals who had received anti-tuberculosis treatment for more than six months. These individuals were monitored over 11 years (132 months) to ...

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB ...

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a ...

Tuberculosis kills 1.3 million people each year, making it the deadliest infectious disease in the world, write KJ Seung and.

In 2023, tuberculosis claimed approximately 1·3 million lives,1 providing a stark reminder of the persistent inequities and ...

No fewer than 50,000 Nigerians have tested positive for tuberculosis (TB) as a result of intensified screening efforts across ...

Given the severity of the issue, ASEAN's regional action plan, established in 2018, to eliminate tuberculosis by 2035, is ...

No fewer than 50,000 Nigerians have tested positive for tuberculosis, following the increased screening efforts nationwide, Global Fund, an international NGO has said.The Fund, however, said that many ...